7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Venous Thrombosis D020246 11 associated lipids
Thinness D013851 11 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Sepsis D018805 11 associated lipids
Aortic Diseases D001018 11 associated lipids
Familial Mediterranean Fever D010505 12 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Osteoporosis D010024 12 associated lipids
Hypocalcemia D006996 12 associated lipids
Crohn Disease D003424 12 associated lipids
Disease Susceptibility D004198 12 associated lipids
Hypercalcemia D006934 13 associated lipids
Multiple Myeloma D009101 13 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Polycythemia Vera D011087 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Angina, Unstable D000789 14 associated lipids
Stomatitis D013280 14 associated lipids
Periodontal Diseases D010510 15 associated lipids
Carotid Stenosis D016893 15 associated lipids
Encephalitis D004660 15 associated lipids
HIV Seropositivity D006679 15 associated lipids
Synovitis D013585 15 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Celiac Disease D002446 16 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Vascular Diseases D014652 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Brain Infarction D020520 17 associated lipids
Albuminuria D000419 18 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
HIV Infections D015658 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Wounds and Injuries D014947 20 associated lipids
Myocardial Infarction D009203 21 associated lipids
Cachexia D002100 21 associated lipids
Periodontitis D010518 22 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Hyperinsulinism D006946 27 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Kidney Diseases D007674 29 associated lipids
Obesity D009765 29 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Hein GE [Pathophysiology of bone loss in rheumatic diseases--do bone markers help in monitoring?]. 2001 Z Rheumatol pmid:11383046
Morony S et al. Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. 2001 Cancer Res. pmid:11389072
Abu-Amer Y IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB. 2001 J. Clin. Invest. pmid:11390419
Kon T et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. 2001 J. Bone Miner. Res. pmid:11393777
Fazzalari NL et al. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. 2001 J. Bone Miner. Res. pmid:11393778
Kim KJ et al. Osteoprotegerin inhibits in vitro mouse osteoclast formation induced by joint fluid from failed total hip arthroplasty. 2001 J. Biomed. Mater. Res. pmid:11410897
Haynes DR et al. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. 2001 Rheumatology (Oxford) pmid:11426018
Szulc P et al. Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. 2001 J. Clin. Endocrinol. Metab. pmid:11443182
Sakiyama H et al. Establishment and characterization of macrophage-like cell lines expressing osteoclast-specific markers. 2001 J. Bone Miner. Metab. pmid:11448014
Choi Y et al. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. 2001 Eur. J. Immunol. pmid:11449372

Table of Content